<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2013-09-30 10:41:54Charles Sawyers The Vilcek Foundation Ján Vilček Dennis Slamon Tyler Jacks James Lewis Abbruzzese Lawrence Einhorn Medicine Oncologists Daniel Von Hoff |
Add to Reading List |
https://ui.constantcontact.com/visualeditor/visual_editor_preview.jsp?agent.uid=[removed]&format=html&printFrame=true | Non-Clinical Factors Influence treatment decisions November 2016 What we discovered… Despite the common understanding that oncologists’ treatment choices areDocID: 1t5H7 - View Document |
| Microsoft Outlook - Memo StyleDocID: 1qEWn - View Document |
| What are we doing? We need your help! The world of dog owners, veterinarians, oncologists and dog geneticists is about toDocID: 1q30v - View Document |
| CABARET: Carboplatin and bevacizumab in recurrent glioblastoma study (Part 1) The CABARET trial is helping researchers answer an important health question. It is providing evidence for oncologists planning treatment forDocID: 1pDeC - View Document |
| Quotes from CCMS Members and Interns “An understanding and appreciation Mini-Internship Chairs Souzan El-Eid, MDDocID: 1pqm1 - View Document |